338 related articles for article (PubMed ID: 18292809)
1. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats.
Morimoto T; Sunagawa Y; Kawamura T; Takaya T; Wada H; Nagasawa A; Komeda M; Fujita M; Shimatsu A; Kita T; Hasegawa K
J Clin Invest; 2008 Mar; 118(3):868-78. PubMed ID: 18292809
[TBL] [Abstract][Full Text] [Related]
2. Curcumin prevents and reverses murine cardiac hypertrophy.
Li HL; Liu C; de Couto G; Ouzounian M; Sun M; Wang AB; Huang Y; He CW; Shi Y; Chen X; Nghiem MP; Liu Y; Chen M; Dawood F; Fukuoka M; Maekawa Y; Zhang L; Leask A; Ghosh AK; Kirshenbaum LA; Liu PP
J Clin Invest; 2008 Mar; 118(3):879-93. PubMed ID: 18292803
[TBL] [Abstract][Full Text] [Related]
3. Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin.
Morimoto T; Sunagawa Y; Fujita M; Hasegawa K
Circ J; 2010 Jun; 74(6):1059-66. PubMed ID: 20467147
[TBL] [Abstract][Full Text] [Related]
4. Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats.
Sunagawa Y; Funamoto M; Shimizu K; Shimizu S; Sari N; Katanasaka Y; Miyazaki Y; Kakeya H; Hasegawa K; Morimoto T
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444769
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
6. Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes.
Katanasaka Y; Sunagawa Y; Hasegawa K; Morimoto T
Biol Pharm Bull; 2013; 36(1):13-7. PubMed ID: 23302632
[TBL] [Abstract][Full Text] [Related]
7. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo.
Miyamoto S; Kawamura T; Morimoto T; Ono K; Wada H; Kawase Y; Matsumori A; Nishio R; Kita T; Hasegawa K
Circulation; 2006 Feb; 113(5):679-90. PubMed ID: 16461841
[TBL] [Abstract][Full Text] [Related]
8. Curcumin and its demethoxy derivatives possess p300 HAT inhibitory activity and suppress hypertrophic responses in cardiomyocytes.
Sunagawa Y; Funamoto M; Sono S; Shimizu K; Shimizu S; Genpei M; Miyazaki Y; Katanasaka Y; Morimoto E; Ueno M; Komiyama M; Kakeya H; Wada H; Hasegawa K; Morimoto T
J Pharmacol Sci; 2018 Apr; 136(4):212-217. PubMed ID: 29602708
[TBL] [Abstract][Full Text] [Related]
9. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
[TBL] [Abstract][Full Text] [Related]
10. [Development of Targeted Pharmacotherapy for Cardiovascular Disease].
Katanasaka Y
Yakugaku Zasshi; 2017; 137(11):1349-1353. PubMed ID: 29093370
[TBL] [Abstract][Full Text] [Related]
11. The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice.
Shimizu K; Sunagawa Y; Funamoto M; Wakabayashi H; Genpei M; Miyazaki Y; Katanasaka Y; Sari N; Shimizu S; Katayama A; Shibata H; Iwabuchi Y; Kakeya H; Wada H; Hasegawa K; Morimoto T
Sci Rep; 2020 Apr; 10(1):7172. PubMed ID: 32346115
[TBL] [Abstract][Full Text] [Related]
12. Currying favor for the heart.
Epstein JA
J Clin Invest; 2008 Mar; 118(3):850-2. PubMed ID: 18292806
[TBL] [Abstract][Full Text] [Related]
13. Optimal dose-setting study of curcumin for improvement of left ventricular systolic function after myocardial infarction in rats.
Sunagawa Y; Sono S; Katanasaka Y; Funamoto M; Hirano S; Miyazaki Y; Hojo Y; Suzuki H; Morimoto E; Marui A; Sakata R; Ueno M; Kakeya H; Wada H; Hasegawa K; Morimoto T
J Pharmacol Sci; 2014; 126(4):329-36. PubMed ID: 25409899
[TBL] [Abstract][Full Text] [Related]
14. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.
Wei JQ; Shehadeh LA; Mitrani JM; Pessanha M; Slepak TI; Webster KA; Bishopric NH
Circulation; 2008 Aug; 118(9):934-46. PubMed ID: 18697823
[TBL] [Abstract][Full Text] [Related]
15. Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice.
Sunagawa Y; Tsukabe R; Irokawa Y; Funamoto M; Suzuki Y; Yamada M; Shimizu S; Katanasaka Y; Hamabe-Horiike T; Kawase Y; Naruta R; Shimizu K; Mori K; Hosomi R; Komiyama M; Hasegawa K; Morimoto T
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397020
[TBL] [Abstract][Full Text] [Related]
16. Curcumin alleviates neuropathic pain by inhibiting p300/CBP histone acetyltransferase activity-regulated expression of BDNF and cox-2 in a rat model.
Zhu X; Li Q; Chang R; Yang D; Song Z; Guo Q; Huang C
PLoS One; 2014; 9(3):e91303. PubMed ID: 24603592
[TBL] [Abstract][Full Text] [Related]
17. A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats.
Sunagawa Y; Morimoto T; Wada H; Takaya T; Katanasaka Y; Kawamura T; Yanagi S; Marui A; Sakata R; Shimatsu A; Kimura T; Kakeya H; Fujita M; Hasegawa K
Circ J; 2011; 75(9):2151-9. PubMed ID: 21737953
[TBL] [Abstract][Full Text] [Related]
18. p300-mediated histone acetylation is essential for the regulation of GATA4 and MEF2C by BMP2 in H9c2 cells.
Zheng M; Zhu J; Lu T; Liu L; Sun H; Liu Z; Tian J
Cardiovasc Toxicol; 2013 Dec; 13(4):316-22. PubMed ID: 23632743
[TBL] [Abstract][Full Text] [Related]
19. Bnip3 Binds and Activates p300: Possible Role in Cardiac Transcription and Myocyte Morphology.
Thompson JW; Wei J; Appau K; Wang H; Yu H; Spiga MG; Graham RM; Webster KA
PLoS One; 2015; 10(8):e0136847. PubMed ID: 26317696
[TBL] [Abstract][Full Text] [Related]
20. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.
Balasubramanyam K; Varier RA; Altaf M; Swaminathan V; Siddappa NB; Ranga U; Kundu TK
J Biol Chem; 2004 Dec; 279(49):51163-71. PubMed ID: 15383533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
